Jess Jankowski - Nov 7, 2022 Form 4 Insider Report for NANOPHASE TECHNOLOGIES Corp (NANX)

Role
President, CEO, Director
Signature
Jess A. Jankowski
Stock symbol
NANX
Transactions as of
Nov 7, 2022
Transactions value $
-$10,503
Form type
4
Date filed
11/9/2022, 06:20 PM
Previous filing
Nov 7, 2022
Next filing
Nov 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NANX Common Stock Options Exercise $623 +1.5K +2.54% $0.42 60.5K Nov 7, 2022 Direct F1
transaction NANX Common Stock Sale -$3.05K -1.5K -2.48% $2.03 59K Nov 7, 2022 Direct
transaction NANX Common Stock Options Exercise $1.25K +3K +5.08% $0.42 62K Nov 8, 2022 Direct F1
transaction NANX Common Stock Sale -$6.81K -3K -4.84% $2.27 59K Nov 8, 2022 Direct
transaction NANX Common Stock Options Exercise $125 +300 +0.51% $0.42 59.3K Nov 9, 2022 Direct F1
transaction NANX Common Stock Sale -$648 -300 -0.51% $2.16 59K Nov 9, 2022 Direct
holding NANX Common Stock 1K Nov 7, 2022 Spouse's IRA
holding NANX Common Stock 59K Nov 7, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NANX Common Stock (right to purchase) Options Exercise -$623 -1.5K -2.03% $0.42 72.5K Nov 7, 2022 Common Stock 74K $0.42 Direct F2
transaction NANX Common Stock (right to purchase) Options Exercise -$1.25K -3K -4.14% $0.42 69.5K Nov 8, 2022 Common Stock 72.5K $0.42 Direct F2
transaction NANX Common Stock (right to purchase) Options Exercise -$125 -300 -0.43% $0.42 69.2K Nov 9, 2022 Common Stock 69.5K $0.42 Direct F2
holding NANX Common Stock (right to purchase) 90K Nov 7, 2022 Common Stock 90K $0.52 Direct F3
holding NANX Common Stock (right to purchase) 81K Nov 7, 2022 Common Stock 81K $0.44 Direct F4
holding NANX Common Stock (right to purchase) 69K Nov 7, 2022 Common Stock 69K $0.42 Direct F4
holding NANX Common Stock (right to purchase) 81K Nov 7, 2022 Common Stock 81K $0.68 Direct F4
holding NANX Common Stock (right to purchase) 90K Nov 7, 2022 Common Stock 90K $0.82 Direct F5
holding NANX Common Stock (right to purchase) 16.5K Nov 7, 2022 Common Stock 16.5K $0.51 Direct F3
holding NANX Common Stock (right to purchase) 90K Nov 7, 2022 Common Stock 90K $0.45 Direct F3
holding NANX Common Stock (right to purchase) 90K Nov 7, 2022 Common Stock 90K $4.17 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options are set to expire on 02/14/2023. Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having his broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
F2 These stock options are set to expire on 02/14/2023. Mr. Jankowski converted and sold these shares through a 10b5-1 Plan that has been established with an independent broker. His goal is to have this broker sell shares from this grant, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors.
F3 Subject to certain restrictions, beginning on this date, options vest in three equal installments.
F4 Subject to certain restrictions, beginning on this date, the options vest in three equal annual installments.
F5 Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.

Remarks:

Mr. Jankowski established a 10b5-1 Plan with an independent broker with a goal of having shares from this grant sold, under fixed guidleines, in a regular and measured manner designed to avoid both forfeiture of shares due to expiration, and impacting the stock price due to excessive trading volume. His Plan was approved in advance by the Compensation & Governance Committee of the Nanophase Board of Directors. The maturity of these rights cannot be extended beyond the IRS statutory limit of ten years.